Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,161 to 2,180 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NASP antagonize chromatin accessibility through maintaining histone H3K9me1 in hepatocellular carcinoma. | Biochim Biophys Acta Mol Basis Dis | 2018 | 30076957 | PubTator, text mining | PubMed |
Interferon-α Is Effective for Treatment of Minimal Residual Disease in Patients with t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Registry Study. | Oncologist | 2018 | 30076280 | PubTator, text mining | PubMed |
| Sno-derived RNAs are prevalent molecular markers of cancer immunity. | Oncogene | 2018 | 30072739 | PubTator, text mining | PubMed |
Gene expression analysis indicates reduced memory and cognitive functions in the hippocampus and increase in synaptic reorganization in the frontal cortex 3 weeks after MDMA administration in Dark Agouti rats. | BMC Genomics | 2018 | 30071829 | PubTator, text mining | PubMed |
| Chromosome integrity checkpoints in stem and progenitor cells: transitions upon differentiation, pathogenesis, and aging. | Cell Mol Life Sci | 2018 | 30066086 | PubTator, text mining | PubMed |
| Link Between m6A Modification and Cancers. | Front Bioeng Biotechnol | 2018 | 30062093 | PubTator, text mining | PubMed |
| Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells. | Cancers (Basel) | 2018 | 30060526 | PubTator, text mining | PubMed |
| Mediation analysis reveals common mechanisms of RUNX1 point mutations and RUNX1/RUNX1T1 fusions influencing survival of patients with acute myeloid leukemia. | Sci Rep | 2018 | 30050054 | PubTator, text mining | PubMed |
| Specific alteration of gene expression profile in rats by treatment with thyroid toxicants that inhibit thyroid hormone synthesis. | J Appl Toxicol | 2018 | 30047161 | PubTator, text mining | PubMed |
| Characterization of TRKA signaling in acute myeloid leukemia. | Oncotarget | 2018 | 30046390 | PubTator, text mining | PubMed |
| [Impact of KIT D816 mutation on salvage therapy in relapsed acute myeloid leukemia with t(8;21) translocation]. | Zhonghua Xue Ye Xue Za Zhi | 2018 | 30032560 | PubTator, text mining | PubMed |
| [How I manage minimal residual disease positive patients with acute leukemia who underwent allogeneic stem cell transplantation]. | Zhonghua Xue Ye Xue Za Zhi | 2018 | 30032558 | PubTator, text mining | PubMed |
| Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis. | Nat Commun | 2018 | 30013160 | PubTator, text mining | PubMed |
Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network. | Ann Hematol | 2018 | 30009341 | PubTator, text mining | PubMed |
| Rapid diagnosis of mixed phenotype acute leukemia after identifying a blood histogram abnormality. | Pract Lab Med | 2018 | 30009244 | PubTator, text mining | PubMed |
| Monitoring immunoglobulin heavy chain and T-cell receptor gene rearrangement in cfDNA as minimal residual disease detection for patients with acute myeloid leukemia. | Oncol Lett | 2018 | 30008930 | PubTator, text mining | PubMed |
| Mitotic Gene Bookmarking: An Epigenetic Program to Maintain Normal and Cancer Phenotypes. | Mol Cancer Res | 2018 | 30002192 | PubTator, text mining | PubMed |
| Murine models based on acute myeloid leukemia-initiating stem cells xenografting. | World J Stem Cells | 2018 | 29988882 | PubTator, text mining | PubMed |
| Aberrant expression of ETS1 and ETS2 proteins in cancer. | Cancer Rep Rev | 2018 | 29974077 | PubTator, text mining | PubMed |
| Regulation of Expression of CEBP Genes by Variably Expressed Vitamin D Receptor and Retinoic Acid Receptor α in Human Acute Myeloid Leukemia Cell Lines. | Int J Mol Sci | 2018 | 29966306 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=109